Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasms.
Gudmundsdottir H, Tomlinson JL, Graham RP, Thiels CA, Warner SG, Smoot RL, Kendrick ML, Nagorney DM, Halfdanarson TR, Habermann EB, Truty MJ, Cleary SP. Gudmundsdottir H, et al. Among authors: tomlinson jl. HPB (Oxford). 2022 Jul;24(7):1186-1193. doi: 10.1016/j.hpb.2021.12.016. Epub 2021 Dec 31. HPB (Oxford). 2022. PMID: 35078716 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 35290694
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
Conboy CB, Yonkus JA, Buckarma EH, Mun DG, Werneburg NW, Watkins RD, Alva-Ruiz R, Tomlinson JL, Guo Y, Wang J, O'Brien D, McCabe CE, Jessen E, Graham RP, Buijsman RC, Vu D, de Man J, Ilyas SI, Truty MJ, Borad M, Pandey A, Gores GJ, Smoot RL. Conboy CB, et al. Among authors: tomlinson jl. J Hepatol. 2023 Jan;78(1):142-152. doi: 10.1016/j.jhep.2022.09.014. Epub 2022 Sep 24. J Hepatol. 2023. PMID: 36162702 Free article.
Immunobiology of cholangiocarcinoma.
Tomlinson JL, Valle JW, Ilyas SI. Tomlinson JL, et al. J Hepatol. 2023 Sep;79(3):867-875. doi: 10.1016/j.jhep.2023.05.010. Epub 2023 May 16. J Hepatol. 2023. PMID: 37201670 Review.
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma.
Loeuillard E, Li B, Stumpf HE, Yang J, Willhite J, Tomlinson JL, Wang J, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI. Loeuillard E, et al. Among authors: tomlinson jl. bioRxiv [Preprint]. 2023 Jul 11:2023.05.24.541931. doi: 10.1101/2023.05.24.541931. bioRxiv. 2023. PMID: 37293061 Free PMC article. Updated. Preprint.
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma.
Loeuillard EJ, Li B, Stumpf HE, Yang J, Willhite JR, Tomlinson JL, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI. Loeuillard EJ, et al. Among authors: tomlinson jl. Cell Mol Gastroenterol Hepatol. 2024;17(5):853-876. doi: 10.1016/j.jcmgh.2024.01.006. Epub 2024 Jan 14. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38219900 Free PMC article.
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis.
Watkins R, Gamo A, Choi SH, Kumar M, Buckarma E, McCabe C, Tomlinson J, Pereya D, Lupse B, Geravandi S, Werneburg NW, Wang C, Starlinger P, Zhu S, Li S, Yu S, Surakattula M, Baguley T, Ardestani A, Maedler K, Roland J, Nguyen-Tran V, Joseph S, Petrassi M, Rogers N, Gores G, Chatterjee A, Tremblay M, Shen W, Smoot R. Watkins R, et al. PNAS Nexus. 2024 Mar 1;3(3):pgae096. doi: 10.1093/pnasnexus/pgae096. eCollection 2024 Mar. PNAS Nexus. 2024. PMID: 38528952 Free PMC article.
65 results